Strategic Positioning:A world-leading innovative animal healthcare company
Description:To become a world-leading innovative animal healthcare company by building a vector vaccine platform with leading reverse genetics technology to develop combination and multivalent vaccines and rapidly form a product pipeline with international market competitiveness, and continuously expanding the R&D technology platform (nucleic acid vaccines) with R&D advantages.
KEXING INVESTMENT SECTOR - ANIMAL VACCINE PIPELINE
Completed the construction of 13 product pipelines, and completed 3 product attack protection experiments.
Product Pipeline
Laboratory Study
Preclinical study
Clinical Study
Product Registration
Swine vaccines
SADS-CoV vector
SADS + PED + PDCoV vaccine
Pseudorabies virus vector
Pseudorabies + bivalent PRRS vaccine
Pseudorabies + bivalent PRRS + bivalent PCV vaccine
Pseudorabies + bivalent PRRS + CSF vaccine
Pseudorabies + bivalent PRRS + bivalent PCV + CSF vaccine
Pet vaccines
Canine adenovirus (CAV) vector
PIV5 vector
PIV5 + rabies vector vaccine
PIV5 + COVID-19 vector vaccine
Feline herpes vector
Feline herpes + feline plague + calicivirus vaccine
Feline herpes + feline plague + calicivirus + rabies + leukemia vaccine
